China Universal Asset Management Company’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
27,194
-1,609
-6% -$56.3K 0.06% 198
2026
Q1
$1.11M Buy
28,803
+3,789
+15% +$140K 0.08% 179
2025
Q4
$888K Buy
25,014
+527
+2% +$14.8K 0.07% 199
2025
Q3
$352K Buy
24,487
+1,619
+7% +$19.2K 0.03% 280
2025
Q2
$164K Buy
22,868
+32
+0.1% +$177 0.02% 328
2025
Q1
$137K Sell
22,836
-586
-3% -$4.59K 0.01% 340
2024
Q4
$183K Buy
23,422
+2,371
+11% +$23.6K 0.02% 335
2024
Q3
$227K Buy
21,051
+9,819
+87% +$95.6K 0.03% 291
2024
Q2
$94.7K Sell
11,232
-8,718
-44% -$66.1K 0.01% 305
2024
Q1
$134K Buy
19,950
+9,989
+100% +$61.7K 0.02% 342
2023
Q4
$58.6K Buy
9,961
+7,772
+355% +$59.6K 0.01% 353
2023
Q3
$21.3K Buy
2,189
+1,259
+135% +$14.9K 0.01% 293
2023
Q2
$11K Sell
930
-17
-2% -$195 ﹤0.01% 311
2023
Q1
$10.2K Buy
947
+237
+33% +$3.03K ﹤0.01% 291
2022
Q4
$8.21K Buy
710
+95
+15% +$1.18K ﹤0.01% 246
2022
Q3
$9K Buy
+615
New +$8.43K ﹤0.01% 213

Other funds holding COGT

China Universal Asset Management Company's COGT Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Cogent Biosciences (COGT) stake by 5.6% in Q2 2026, selling an estimated $56.3K and leaving 27,194 shares worth $1.05M. The position accounts for 0.06% of the portfolio, ranked #198.

China Universal Asset Management Company first reported a position in COGT in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.11M in Q1 2026. 143 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • China Universal Asset Management Company held 27,194 shares of Cogent Biosciences worth $1.05M as of Q2 2026.
  • China Universal Asset Management Company sold 1,609 Cogent Biosciences shares in Q2 2026, an estimated $56.3K.
  • Cogent Biosciences made up 0.06% of China Universal Asset Management Company's portfolio in Q2 2026, its #198 holding.
  • China Universal Asset Management Company first reported a position in Cogent Biosciences in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Cogent Biosciences position peaked at $1.11M in Q1 2026.
  • 143 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.